Analogues of the hepatokine fibroblast growth factor 21 (FGF21) are in clinical development
for type 2 diabetes and nonalcoholic steatohepatitis (NASH) treatment. Although their …

Analogues of the hepatokine FGF21 are in clinical development for type 2 diabetes and
nonalcoholic steatohepatitis (NASH) treatment. Although their glucose-lowering and insulin-…

Analogues of the hepatokine fibroblast growth factor 21 (FGF21) are in clinical development
for type 2 diabetes and nonalcoholic steatohepatitis (NASH) treatment. Although their …

Contemporary society demands frequent shifts between attentive tasks, also known as
multitasking. Gender stereotypes imply that women outperform men when it comes to multitasking…

Background and Objective Secukinumab, an anti-interleukin (IL)-17A monoclonal antibody,
has demonstrated low radiographic progression over 4 years in patients with ankylosing …

There have been major advances in the management of axial spondyloarthritis (axSpA) with
the introduction of effective biologic agents targeting TNF and IL-17A. Clinicians now have …

… Besides, I would like to thank the interns in our research group, especially my students Mik,
Borah, and Zikuan, for their amazing help. Without your help, I could not have completed all …

We investigated whether the bone-synthetic activities of vertebral bodies or vertebral corners
quantified using 18 F-fluoride positron emission tomography (PET) was associated with …

Although better science and technology has been linked with better health care, however,
reality is much different. Although America and most of Europe are equipped with most …

Introduction Decreasing the diagnostic delay in axial spondyloarthritis (axSpA) remains a
major challenge. Here, we assessed the value of serum inflammatory biomarkers to distinguish …